ATG5, ATG7, BECN1, ESR1, IL6, BCL2, and other gene targets are important in the regulatory network, indicating that these genes are involved in the occurrence and development of CKD and are regulated by CCYSD in different degrees, which may be central targets for the therapeutic effect of CCYSD. The gene discussed is BCL2; the disease is chronic kidney disease.